close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ALPMY

Recent news which mentions ALPMY

< Previous 1 2 Next >
Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them
Tickers ALPMY AMZN BKNG BUD
Tags Super Bowl ads Ben Affleck U2
From Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Tickers ALPMF ALPMY HZNP SELB
Tags ALPMF Market News SELB
From Benzinga
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
Tickers ALPMF ALPMY GSK NVS
Tags Briefs M&A General
From Benzinga
What Is Going on With Taysha Gene (TSHA) Stock Today?
Tickers ALPMY TSHA
Tags NASDAQ:TSHA,OTCMKTS:ALPMY Market News Today's Market
From InvestorPlace
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs
Tickers ALPMF ALPMY TSHA
Tags Pre/Market Outlook Penny Stocks News
From Benzinga
Astellas' Menopause Drug Under FDA Review
Tickers ALPMF ALPMY
Tags Health Care Market News ALPMF
From Benzinga
Seagen Shares Jump On Positive Data From Urothelial Cancer Trial
Tickers ALPMF ALPMY MRK SGEN
Tags Briefs Trading Ideas MRK
From Benzinga
7 Best Biotech Stocks to Buy in July 2022
Tickers AAPL ALPMY AMGN AZN
Tags MRK MSFT DNA
From InvestorPlace
Sutro Biopharma Stock Surges On Cancer Treatment Pact
Tickers ALPMF ALPMY STRO
Tags STRO Briefs Trading Ideas
From Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Tickers ALPMF ALPMY AXSM AZN
Tags ALPMY DSKYF Contracts
From Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
Tickers ALPMF ALPMY
Tags Market News ALPMF Health Care
From Benzinga
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
Tickers ALPMF ALPMY TWST
Tags Biotech Benzinga Briefs
From Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
Tickers ALPMF ALPMY SGEN
Tags Benzinga Biotech European Medicines Agency
From Benzinga
Astellas' Menopause Drug Suffers Setback After Failed Asian Trial
Tickers ALPMF ALPMY
Tags Briefs Benzinga Biotech
From Benzinga
Got $1,000? Here's a Dirt-Cheap Big Pharma Stock to Buy
Tickers ALPMY BMY BNTX JNJ
Tags BMY JNJ Market News
From Motley Fool
Astellas Touts Safety Data For Phase 3 Menopause Drug, Sets Up US Filing
Tickers ALPMF ALPMY
Tags ALPMF Market News Health Care
From Benzinga
Astellas Pharma - Seagen's Enfortumab Shows 36% Pathologic Complete Response In Bladder Cancer Patients
Tickers ALPMF ALPMY SGEN
Tags Biotech Benzinga Health Care
From Benzinga
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
Tickers ADAP AGEN ALPMY GSK
Tags Recent Press Releases RHHBY GSK
From Motley Fool
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Tickers ALPMF ALPMY NVS RHHBF
Tags General News Briefs
From Benzinga
Astellas Pharma's Bladder Cancer Treatment Scores Approval In Japan
Tickers ALPMF ALPMY
Tags Briefs FDA Biotech
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Tickers ABT ACAD ADGI ALPMY
Tags NNVC NVCR RHHBY
From Benzinga
Astellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Hold
Tickers ALPMF ALPMY
Tags News General gene therapy
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Tickers ACIU ADGI ALKS ALPMY
Tags STIM ERAS DRMA
From Benzinga
See Why Astellas Stopped Dosing In Neuromuscular Disease Gene Therapy Trial
Tickers ALM ALPMF ALPMY
Tags Health Care ALM ALPMF
From Benzinga
After FDA Rejection, EMA Approves FibroGen-Astellas' Roxadustat
Tickers AKBA ALPMF ALPMY AZN
Tags Briefs Trading Ideas Anemia
From Benzinga
Here's What Recent News From the FDA Means for AstraZeneca
Tickers ALPMY AZN FGEN
Tags Market News AZN FGEN
From Motley Fool
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Tickers ABVC ACAD ACET ADMA
Tags HEPA CBIO RXRX
From Benzinga
FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial
Tickers ALPMF ALPMY AZN FGEN
Tags Small Cap ALPMY Health Care
From Benzinga
Why Investors Should Like BioNTech's Latest Deal With Gilead
Tickers ALPMY BNTX GILD PFE
Tags Market News PFE ALPMY
From Motley Fool
The IPO Recap – Party Is Everything But Over
Tickers ABSI ALPMY BASE CNM
Tags Benzinga LAW CNM
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today